Postmarketing safety evaluation of pemetrexed using FAERS and JADER databases
Abstract Pemetrexed, a multi-target antifolate chemotherapeutic widely used in non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma (MPM), is associated with various adverse drug events (ADEs), some of which may be underrecognized in clinical trials. This study conducted a comprehen...
Saved in:
| Main Authors: | Luo Lv, Xiangyang Wu, Yubo Ren, Yuli Guo, Haixiong Wang, Xiaofang Li |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-05-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-02426-9 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Risk assessment of the top 50 drugs associated with drug-induced orthostatic hypotension: a disproportionality analysis of the FAERS and JADER databases
by: Gaocan Ren, et al.
Published: (2025-03-01) -
Post-marketing safety profile of ganirelix in women: a 20-year pharmacovigilance analysis of global adverse drug event databases (2004–2024)
by: Yang Yang, et al.
Published: (2025-04-01) -
Disproportionality analysis of adverse events associated with ipilimumab and nivolumab combination therapy based on FAERS database
by: Xianyu Dai, et al.
Published: (2025-07-01) -
A real-world pharmacovigilance study of Certolizumab pegol based on FAERS database
by: Meng Liu, et al.
Published: (2025-08-01) -
A disproportionality analysis of cardiac arrhythmia associated with bisphosphonates based on the FAERS database
by: Feifei Wang, et al.
Published: (2025-07-01)